Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Long-Term Outcome of Molecularly Defined Oligodendrogliomas: Comparison of Grade 2 and 3 Tumors.

Neurology·2026

Same author

Vanishing Aortic Valve Cusp: A Rare Case of Aortic Valve Insufficiency in a Durable Left Ventricular Assist Device Recipient After Micro-Axial Flow Pump Support.

Artificial organs·2026

Same author

Update of the MSKCC nomogram for metastatic progression and its role in active surveillance: the Italian TPCP cohort.

Frontiers in oncology·2026

Same author

Modulating CD38 enzymatic activity during antibody-based immunotherapy in multiple myeloma: a basic science perspective.

Frontiers in immunology·2026

Same author

Role of hypertrophic adipocytes, collagen VI, and CD38 in adipose tissue fibrosis in obesity.

Scientific reports·2026

Same author

The clinical impact of precise assessment of predictive biomarkers in gastroesophageal cancer: focus on the PD-L1 combined positive score (CPS) and tumor area positivity (TAP) systems.

Pathologica·2026

Search research articles

Related Experiment Video

Updated: Jun 20, 2026

Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology

Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology

Published on: March 21, 2018

TfR2 expression in human colon carcinomas.

Alessia Calzolari¹, Silvia Deaglio, Elena Maldi

¹Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.

Blood Cells, Molecules & Diseases

|September 5, 2009

Summary

This summary is machine-generated.

The second transferrin receptor (TfR2) is found in colon cancer cells, not just the liver. This TfR2 expression may promote cancer cell growth and is linked to specific tumor types.

More Related Videos

Isolation of Human Endothelial Cells from Normal Colon and Colorectal Carcinoma - An Improved Protocol

Isolation of Human Endothelial Cells from Normal Colon and Colorectal Carcinoma - An Improved Protocol

Published on: April 4, 2018

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

Related Experiment Videos

Last Updated: Jun 20, 2026

Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology

Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology

Published on: March 21, 2018

Isolation of Human Endothelial Cells from Normal Colon and Colorectal Carcinoma - An Improved Protocol

Isolation of Human Endothelial Cells from Normal Colon and Colorectal Carcinoma - An Improved Protocol

Published on: April 4, 2018

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

Area of Science:

Biochemistry
Molecular Biology
Oncology

Background:

Iron metabolism is crucial for cellular function and is tightly regulated by specific proteins.
The second transferrin receptor (TfR2) plays a significant role in iron homeostasis, with normal expression primarily in the liver.
TfR2 has been observed in various cancer cell lines, suggesting a potential role in cancer development.

Purpose of the Study:

To investigate the expression of TfR2 in primary colon cancers.
To determine the correlation between TfR2 expression and clinicopathological features of colon cancer.
To elucidate the functional role and cellular localization of TfR2 in colon cancer.

Main Methods:

Immunohistochemistry was used to assess TfR2 expression in primary colon cancer tissues.
Colon cancer cell lines were utilized to study TfR2 localization and function.
Cell cycle analysis and Western blotting were performed to examine TfR2 activity and its downstream effects.

Main Results:

TfR2 was expressed in approximately 26% of primary colon cancer cases.
TfR2 expression was not associated with histological grade but showed a preference for mucinous tumors.
In colon cancer cells, TfR2 localizes to membrane lipid rafts, induces ERK1/ERK2 phosphorylation upon transferrin binding, and is expressed during the S-M phases of the cell cycle.

Conclusions:

TfR2 is expressed in a subset of colon cancers, particularly mucinous types.
The presence and activation of TfR2 on colon cancer cells may confer a growth advantage.
Targeting TfR2 could be a potential therapeutic strategy for colon cancer.